DV
Dividend Vision

ASMB — Assembly Biosciences Inc

Assembly Biosciences Inc (ASMB)

Total return is -91.3% over the past 15.7 years, 812.1 points behind SPY at 720.8%. Its deepest 1-year drawdown was 42.2%.

Assembly Biosciences Inc is an individual equity stock in the biopharmaceutical sector focused on developing treatments for viral diseases. The stock does not currently pay dividends, as indicated by its N/A distribution rate, and therefore generates returns primarily through capital appreciation rather than income. This equity holding appeals primarily to growth-oriented investors seeking exposure to the biotech industry rather than income-focused investors seeking regular dividend distributions.

ASMB key facts

Asset type
Stock
Asset class
Equity
Inception date
12/17/2010
Last close
$32.95
Market cap
$531,300,448
Average volume
559100.0
Beta
1.083
Payout ratio
0.0
P/E ratio
335.125
Forward P/E
15.2439
EPS
$0.08